Abbott’s Established Pharmaceuticals Division (EPD), headquartered in Basel, Switzerland, is focused on helping make the world a healthier place by bringing the benefits of trusted pharmaceutical brands to much broader patient populations – in the developed world and, particularly, in the fastest growing markets.

LOCALLY DRIVEN, GLOBALLY POWERED focused on emerging markets. We have built our pharmaceuticals business to be driven locally and powered globally, which hel care, and who pays the bill locally-focused business model. Global scale and local presence sets Abbott up for long-term success in meeting people’s health needs in emerging markets.

2017年12月6日 · Patients and doctors in emerging markets want more than just high-quality medicines, says Andrew Lane, executive vice president of Abbott's Established Pharmaceuticals Division (EPD) that sells branded generic drugs solely in fast-growing emerging countries.

2018年10月26日 · Abbott’s chairman and chief executive officer, Miles White, says that the firm’s Established Pharmaceuticals Division (EPD) branded generics business focused specifically on key emerging markets “continues to execute its strategy and grow faster than the market in several of our priority countries, including India and China”.

2024年6月24日 · Within Abbott’s Established Pharmaceuticals Division (EPD) business, banking on the successful execution of its Branded Generic operating model, EPD is well positioned...

2025年3月11日 · Abbott’s Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre.

2023年5月8日 · Abbott exited the first quarter of 2023 with better-than-expected earnings and revenues. Organic sales growth excluding COVID testing increased 10%, led by double-digit …

2023年6月12日 · Abbott exited the first quarter of 2023 with better-than-expected earnings and revenues. Organic sales growth, excluding COVID testing, increased 10%, led by double-digit …

Abbott’s Established Pharmaceuticals Division (EPD), headquartered in Basel, Switzerland, is focused on helping make the world a healthier place by bringing the benefits of trusted pharmaceutical brands to much broader patient populations – in the developed world and, particularly, in the fastest growing markets.

2023年2月13日 · During 2022, Abbott successfully continued with the rollout of Alinity, the company’s innovative suite of diagnostic instruments, and expanded test menus across its platforms for immunoassay ...